Shattuck Labs Stock Discussion

$Shattuck Labs(STTK.US)$
NEWS
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
Shattuck Labs, Inc. reveals preclinical data at AACR Annual Meeting 2024 showing TRIM7 inhibition can combat immune checkpoint therapy resistance. TRIM7 inhibitors may reverse acquired resistance to PD-1/L1 blockade, potentially benefiting cancer patients.

$Shattuck Labs(STTK.US)$ Shattuck Labs Announces Drug Discovery Collaboration With Ono Pharmaceutical, For Bifunctional Fusion Proteins Targeting Certain Autoimmune And Inflammatory Disease Pathways, Shattuck To Receive Upfront And Be Eligible For Milestone Payments Of Upto $227M

$Shattuck Labs(STTK.US)$ 7.50 after hours 🚀🚀🚀🚀

$Shattuck Labs(STTK.US)$ 8.00 now 🚀🚀🚀🚁